Pfizer sells entire stake in Haleon via secondary offering
(Alliance News) - Pfizer Inc on Tuesday said it will sell its entire residual stake in Haleon PLC, offloading approximately 662 million shares in the consumer health firm through a secondary offering and a share buyback agreement with Haleon. Read More